Annual Retained Earnings
-$32.07 M
-$11.28 M-54.27%
December 1, 2023
Summary
- As of February 10, 2025, NRSN annual retained earnings is -$32.07 million, with the most recent change of -$11.28 million (-54.27%) on December 1, 2023.
- During the last 3 years, NRSN annual retained earnings has fallen by -$27.66 million (-627.95%).
- NRSN annual retained earnings is now -1933.35% below its all-time high of -$1.58 million, reached on December 31, 2019.
Performance
NRSN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$34.53 M
-$2.15 M-6.63%
September 1, 2024
Summary
- As of February 10, 2025, NRSN quarterly retained earnings is -$34.53 million, with the most recent change of -$2.15 million (-6.63%) on September 1, 2024.
- Over the past year, NRSN quarterly retained earnings has dropped by -$3.00 million (-9.53%).
- NRSN quarterly retained earnings is now -683.88% below its all-time high of -$4.41 million, reached on December 31, 2020.
Performance
NRSN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NRSN Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.3% | -9.5% |
| 3 y3 years | -628.0% | -135.8% |
| 5 y5 years | -1933.3% | - |
NRSN Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -279.7% | at low | -308.8% | at low |
| 5 y | 5-year | -1933.3% | at low | -683.9% | at low |
| alltime | all time | -1933.3% | at low | -683.9% | at low |
NeuroSense Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$34.53 M(+6.6%) |
| Jun 2024 | - | -$32.38 M(+2.7%) |
| Mar 2024 | - | -$31.52 M(-1.7%) |
| Dec 2023 | -$32.07 M(+54.3%) | -$32.07 M(+10.1%) |
| Sep 2023 | - | -$29.12 M(-2.6%) |
| Jun 2023 | - | -$29.90 M(+21.2%) |
| Mar 2023 | - | -$24.68 M(+18.7%) |
| Dec 2022 | -$20.79 M | -$20.79 M(+17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$17.64 M(+20.4%) |
| Jun 2022 | - | -$14.64 M(+31.2%) |
| Mar 2022 | - | -$11.16 M(+32.1%) |
| Dec 2021 | -$8.45 M(+91.7%) | - |
| Dec 2021 | - | -$8.45 M(+13.3%) |
| Jun 2021 | - | -$7.46 M(+69.3%) |
| Dec 2020 | -$4.41 M(+179.3%) | -$4.41 M |
| Dec 2019 | -$1.58 M | - |
FAQ
- What is NeuroSense Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual retained earnings year-on-year change?
- What is NeuroSense Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly retained earnings year-on-year change?
What is NeuroSense Therapeutics annual retained earnings?
The current annual retained earnings of NRSN is -$32.07 M
What is the all time high annual retained earnings for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual retained earnings is -$1.58 M
What is NeuroSense Therapeutics annual retained earnings year-on-year change?
Over the past year, NRSN annual retained earnings has changed by -$11.28 M (-54.27%)
What is NeuroSense Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NRSN is -$34.53 M
What is the all time high quarterly retained earnings for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly retained earnings is -$4.41 M
What is NeuroSense Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NRSN quarterly retained earnings has changed by -$3.00 M (-9.53%)